Prudential Financial Inc Rigel Pharmaceuticals Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.12 - $1.57 $1,232 - $1,727	1,100 Added 1.78%	62,957 $93,000
Q1 2023 May 12, 2023	SELL	$1.25 - $2.0 $223,000 - $356,800	-178,400 Reduced 74.25%	61,857 $81,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $33,768 - $599,760	50,400 Added 26.55%	240,257 $0
Q3 2022 Nov 04, 2022	BUY	$1.1 - $12.2 $196,240 - $2.18 Million	178,400 Added 1557.13%	189,857 $224,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $2,489 - $3,766	-1,055 Reduced 8.43%	11,457 $30,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $3,150 - $4,050	900 Added 7.75%	12,512 $45,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $1,421 - $2,088	460 Added 4.12%	11,612 $50,000
Q1 2021 May 12, 2021	SELL	$3.35 - $4.93 $5,996 - $8,824	-1,790 Reduced 13.83%	11,152 $38,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $799 - $1,271	340 Added 2.7%	12,942 $45,000
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $16,634 - $38,594	-9,345 Reduced 42.58%	12,602 $30,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $13,782 - $20,038	9,775 Added 80.31%	21,947 $40,000
Q1 2020 May 12, 2020	BUY	$1.27 - $3.0 $1,473 - $3,480	1,160 Added 10.53%	12,172 $18,000
Q3 2019 Nov 13, 2019	SELL	$1.63 - $2.62 $4,498 - $7,231	-2,760 Reduced 20.04%	11,012 $20,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $2,740 - $3,630	1,370 Added 11.05%	13,772 $0
Q4 2018 Feb 07, 2019	SELL	$2.08 - $3.36 $1,892 - $3,057	-910 Reduced 6.84%	12,402 $28,000
Q3 2018 Nov 07, 2018	SELL	$2.6 - $3.59 $2,678 - $3,697	-1,030 Reduced 7.18%	13,312 $0
Q2 2018 Aug 13, 2018	BUY	$2.83 - $4.11 $6,254 - $9,083	2,210 Added 18.22%	14,342 $0
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $2,648 - $3,526	820 Added 7.25%	12,132 $47,000
Q3 2017 Nov 02, 2017	BUY	$2.18 - $2.57 $24,660 - $29,071	11,312	11,312 $29,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account